Risk of prostate cancer associated with benign prostate disease: a primary care case-control study

Buckley, Brian S.; Lapitan, Marie Carmela M.; Simpson, Colin R.; Sheikh, Aziz
November 2011
British Journal of General Practice;Nov2011, Vol. 61 Issue 592, p664
Academic Journal
The article discusses a study on the association between the benign diseases of prostate over 5 years in a representative Scottish community-based population. It tested the theory that some recorded diagnoses of benign disease may actually indicate the early stages of the diagnostic process for prostate cancer. It suggests that there is no significant increase risk of prostate cancer in men with prostate symptoms where a cancer diagnosis cannot be confirmed within the first 6 months to a year.


Related Articles

  • I Will Forgive You–This Time. Madrigal, Emilio // International Journal of Surgical Pathology;Jun2014, Vol. 22 Issue 4, p334 

    The article presents a case study of 74-year-old man who died of undiagnosed prostate cancer and whose clinical examination revealed several amatory neoplastic cells surrounding a nerve bundle and molding it into the shape of a heart. It mentions that extent of involvement by the prostate...

  • Localised prostate cancer and brachy therapy.  // GP: General Practitioner;10/17/2008, p25 

    The article offers information on the implication of prostate cancer among men in Great Britain. It is considered the most common form of cancer that inflicts men in the country, wherein it accounts for around 25% of all new male cancer diagnosis. It usually develops in men over 50 years of age...

  • Fusion biopsy improves accuracy in prostate cancer diagnosis. SIBAL, MEG // Filipino Reporter;9/9/2016, Vol. 44 Issue 41, p15 

    The article reports that fusion biopsy has improved accuracy in prostate cancer diagnosis over the usual ultrasound-guided biopsy method. Topics include ultrasound often having chances of failing to reveal prostate cancers, the fusion biopsy involves a combination of MRI ((magnetic resonance...

  • CANCER ADVANCES IN FOCUS: Prostate Cancer.  // Cancer Advances in Focus: Prostate Cancer;2010, p1 

    The article focuses on the diagnosis, screening and treatment options for prostate cancer. It discusses the 94 new cases per 100,000 men diagnosed as the yearly prostate cancer incidence rate in the U.S. in 1975. It explores the treatment of hormonal therapy for men with more advanced disease...

  • Identification of pathologically insignificant prostate cancer is not accurate in unscreened men. Shaw, G L; Thomas, B C; Dawson, S N; Srivastava, G; Vowler, S L; Gnanapragasam, V J; Shah, N C; Warren, A Y; Neal, D E // British Journal of Cancer;5/13/2014, Vol. 110 Issue 10, p2405 

    Background:Identification of men harbouring insignificant prostate cancer (PC) is important in selecting patients for active surveillance. Tools have been developed in PSA-screened populations to identify such men based on clinical and biopsy parameters.Methods:Prospectively collected case...

  • NO PSA Testing for Older Men.  // Clinician Reviews;Sep2008, Vol. 18 Issue 9, p10 

    The article discusses research being done on prostate-specific antigen (PSA) screening for prostate cancer in older men in the U.S. It references a study by K. Lin, R. Lipsitz, T. Miller and S. Janakiraman, published in the 2008 issue of the "Annals of Internal Medicine." Lin and colleagues...

  • A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Marcus, D M; Goodman, M; Jani, A B; Osunkoya, A O; Rossi, P J // Prostate Cancer & Prostatic Diseases;2012, Vol. 15 Issue 3, p283 

    Background:The American Joint Commission on Cancer (AJCC) identifies five rare variants of prostate adenocarcinoma: mucinous, ductal, signet ring cell, adenosquamous and neuroendocrine including small cell. No prior study has comprehensively detailed incidence and outcomes for all AJCC variants...

  • Fewer Men Being Screened for Prostate Cancer. Norton, Amy // Tennessee Tribune;11/26/2015, Vol. 26 Issue 48, p8B 

    The article reports on the decline in incidence and the decline in the proportion of men who are diagnosed with prostate cancer in the U.S.

  • Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy. Moses, Kelvin A.; Chen, Ling Y.; Sjoberg, Daniel D.; Bernstein, Melanie; Touijer, Karim A. // BMC Urology;2014, Vol. 14 Issue 1, p1 

    Background Black men with prostate cancer are diagnosed at a younger age, present with more aggressive disease, and experience higher mortality. We sought to assess pathological features and biochemical recurrence (BCR) in young men undergoing radical prostatectomy (RP) to determine if there is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics